IBUPAP Study for Pain Management in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 30, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

July 30, 2020

Conditions
Pain Management
Interventions
DRUG

Ibuprofen

Oral Ibuprofen at 10 mg/kg dose

DRUG

APAP

Oral APAP at 15mg/kg dose

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER

NCT03088800 - IBUPAP Study for Pain Management in Children | Biotech Hunter | Biotech Hunter